139 related articles for article (PubMed ID: 10384241)
1. Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity.
Wlodawer A
Adv Virus Res; 1999; 52():335-50. PubMed ID: 10384241
[TBL] [Abstract][Full Text] [Related]
2. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations.
Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM
Structure; 1996 Jan; 4(1):89-96. PubMed ID: 8805516
[TBL] [Abstract][Full Text] [Related]
3. Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity.
Bujacz G; Alexandratos J; Wlodawer A; Merkel G; Andrake M; Katz RA; Skalka AM
J Biol Chem; 1997 Jul; 272(29):18161-8. PubMed ID: 9218451
[TBL] [Abstract][Full Text] [Related]
4. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.
Lubkowski J; Yang F; Alexandratos J; Wlodawer A; Zhao H; Burke TR; Neamati N; Pommier Y; Merkel G; Skalka AM
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4831-6. PubMed ID: 9560188
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
Yang ZN; Mueser TC; Bushman FD; Hyde CC
J Mol Biol; 2000 Feb; 296(2):535-48. PubMed ID: 10669607
[TBL] [Abstract][Full Text] [Related]
6. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2000 Apr; 53(4):308-15. PubMed ID: 10685051
[TBL] [Abstract][Full Text] [Related]
7. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.
Balasubramanian S; Rajagopalan M; Bojja RS; Skalka AM; Andrake MD; Ramaswamy A
J Biomol Struct Dyn; 2017 Dec; 35(16):3469-3485. PubMed ID: 27835934
[TBL] [Abstract][Full Text] [Related]
8. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase.
Lubkowski J; Yang F; Alexandratos J; Merkel G; Katz RA; Gravuer K; Skalka AM; Wlodawer A
J Biol Chem; 1998 Dec; 273(49):32685-9. PubMed ID: 9830010
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of retroviral integrase.
Maertens GN; Engelman AN; Cherepanov P
Nat Rev Microbiol; 2022 Jan; 20(1):20-34. PubMed ID: 34244677
[TBL] [Abstract][Full Text] [Related]
11. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.
Konsavage WM; Sudol M; Katzman M
Virology; 2008 Sep; 379(2):223-33. PubMed ID: 18687451
[TBL] [Abstract][Full Text] [Related]
12. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant.
Bujacz G; Alexandratos J; Qing ZL; Clément-Mella C; Wlodawer A
FEBS Lett; 1996 Dec; 398(2-3):175-8. PubMed ID: 8977101
[TBL] [Abstract][Full Text] [Related]
13. Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives.
Ouali M; Laboulais C; Leh H; Gill D; Desmaële D; Mekouar K; Zouhiri F; d'Angelo J; Auclair C; Mouscadet JF; Le Bret M
J Med Chem; 2000 May; 43(10):1949-57. PubMed ID: 10821707
[TBL] [Abstract][Full Text] [Related]
14. Purification of untagged retroviral integrases by immobilized metal ion affinity chromatography.
Asante-Appiah E; Merkel G; Skalka AM
Protein Expr Purif; 1998 Feb; 12(1):105-10. PubMed ID: 9473464
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics studies on the HIV-1 integrase catalytic domain.
Lins RD; Briggs JM; Straatsma TP; Carlson HA; Greenwald J; Choe S; McCammon JA
Biophys J; 1999 Jun; 76(6):2999-3011. PubMed ID: 10354426
[TBL] [Abstract][Full Text] [Related]
16. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.
Cox AG; Nair V
Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination of non-lysine residues in the retroviral integrase.
Wang Z; Hou X; Wang Y; Xu A; Cao W; Liao M; Zhang R; Tang J
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):57-62. PubMed ID: 29054407
[TBL] [Abstract][Full Text] [Related]
18. Localization of ASV integrase-DNA contacts by site-directed crosslinking and their structural analysis.
Peletskaya E; Andrake M; Gustchina A; Merkel G; Alexandratos J; Zhou D; Bojja RS; Satoh T; Potapov M; Kogon A; Potapov V; Wlodawer A; Skalka AM
PLoS One; 2011; 6(12):e27751. PubMed ID: 22145019
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.
Maignan S; Guilloteau JP; Zhou-Liu Q; Clément-Mella C; Mikol V
J Mol Biol; 1998 Sep; 282(2):359-68. PubMed ID: 9735293
[TBL] [Abstract][Full Text] [Related]
20. Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets.
Chen IJ; Neamati N; Nicklaus MC; Orr A; Anderson L; Barchi JJ; Kelley JA; Pommier Y; MacKerell AD
Bioorg Med Chem; 2000 Oct; 8(10):2385-98. PubMed ID: 11058033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
